Fungal empyema thoracis complicating treatment of oesophageal carcinoma

Treatment of empyema thoracis.

Fungal empyema thoracis in cancer patients.

OBJECTIVES Fungal empyema thoracis (FET) is a rare life-threatening infection. We sought to describe the clinical characteristics of FET in a large academic cancer center. METHODS We conducted a retrospective chart review of all cancer patients who had a fungal isolate from the pleural fluid culture between 1/2005 and 8/2013. RESULTS A total of 106 fungal isolates were identified in 97 pati...

Fungal empyema thoracis: an emerging clinical entity.

STUDY OBJECTIVES To analyze the clinical spectra, pathogenesis, treatment, outcome, and prognostic factors of fungal empyema thoracis. DESIGN The medical records of patients with positive fungal cultures from pleural effusions were retrospectively analyzed. SETTING A university-based tertiary care hospital in Taipei, Taiwan. PATIENTS AND METHODS From January 1990 through December 1997, pa...

Pyopneumopericardium and empyema thoracis from perforated oesophageal cancer.

Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Division of Cardiology, Department of Medicine, Faculty of Medicine, Chulalongkorn Univers...

Empyema Thoracis

Epmyema thoracis is associated with high mortality ranging between 6% to 24%. The incidence of empyema is increasing in both children and adults; the cause of this surge is unknown. Most cases of empyema complicate community- or hospital-acquired pneumonia but a proportion results from iatrogenic causes or develops without pneumonia. Parapneumonic effusions (PPE) develop in about one half of th...